Best Multisample Blood Collection Needle Suppliers in the U.S.: BD, Greiner Bio-One, and More

Summary

• BD, Greiner Bio-One, Cardinal Health, McKesson, Medline, and Henry Schein are among the most important U.S. purchasing channels and manufacturers to evaluate for multisample blood collection needles.
• The best supplier is determined by more than unit price: facilities should compare safety features, gauge and length options, compatibility, regulatory documentation, availability, contract terms, and total cost of ownership.
• Healthcare organizations should validate every needle and holder combination, follow OSHA and CDC requirements, and use purchasing data, staff feedback, and needlestick-prevention performance to guide supplier selection.

Multisample blood collection needles are fundamental supplies for hospitals, outpatient laboratories, physician offices, urgent care centers, Mobile Phlebotomy services, and long-term care facilities. These needles are designed to connect to a tube holder and allow blood to be drawn into multiple evacuated collection tubes during one Venipuncture. Because a single procedure may involve several tubes for hematology, chemistry, coagulation, blood banking, or molecular testing, the quality and reliability of the needle can directly affect patient comfort, Specimen Integrity, Workflow efficiency, and employee safety.

Healthcare facilities in the United States have many purchasing options. They may buy directly from a medical-device manufacturer, through a national distributor, through a group purchasing organization, or from a regional laboratory-supply vendor. The most suitable supplier depends on the organization’s clinical setting, annual usage, existing contracts, safety program, preferred tube system, and distribution requirements.

Several companies have established strong positions in the U.S. blood-collection market. BD, Greiner Bio-One, Cardinal Health, McKesson, Medline, and Henry Schein are frequently considered during sourcing projects. Other manufacturers and distributors may also be appropriate, especially when a facility needs a particular gauge, length, safety mechanism, price point, or private-label arrangement. The important issue is to evaluate the complete supply relationship rather than selecting a product solely because it has the lowest quoted price.

Understanding Multisample Blood Collection Needles

A conventional multisample needle generally consists of a double-ended needle. The patient-facing end enters the vein, while the opposite end penetrates the rubber stopper of an evacuated blood collection tube. A threaded or otherwise compatible connection attaches the needle to a tube holder. Once the first tube is filled, it can be removed and replaced with another without removing the needle from the patient’s vein.

Most facilities purchase needles in several gauges and lengths. Common options include 21-gauge and 22-gauge needles for routine adult Venipuncture, with 23-gauge products frequently used for smaller or more fragile veins. Shorter needles may be selected for superficial veins, while longer needles may be required for particular patients or collection techniques. Butterfly-style blood collection sets are often used when vein access is difficult, although they are a distinct product category and generally cost more than a standard multisample needle.

Needles may be sold as non-safety devices or as safety-engineered devices. Safety versions can include a hinged shield, sliding shield, blunt mechanism, or other feature intended to reduce exposure to the sharp after use. In the United States, safety-engineered devices are especially important because employers covered by the Occupational Safety and Health Administration’s Bloodborne Pathogens Standard must evaluate and implement safer medical devices when appropriate.

Product selection also involves compatibility. A needle must work correctly with the facility’s tube holder, evacuated tube system, and blood collection procedure. Although many components are manufactured to widely used dimensions, healthcare organizations should not assume that every combination performs identically. Before a conversion, the laboratory, nursing department, infection-prevention team, and Supply Chain group should conduct a practical evaluation.

Leading Suppliers and Purchasing Channels

BD

Becton, Dickinson and Company, commonly known as BD, is one of the best-known medical-device manufacturers in the blood collection and specimen-management market. Its product portfolio includes conventional multisample needles, safety blood collection needles, tube holders, blood collection sets, evacuated tubes, and related accessories. BD’s broad product range can be attractive to hospitals that want to standardize several components with one manufacturer.

One advantage of evaluating BD is the depth of its clinical and operational product offering. A health system may be able to coordinate needles with existing BD tube systems, safety devices, specimen labels, and collection accessories. Large facilities may also benefit from manufacturer support, product training, implementation assistance, and established distribution arrangements.

Potential limitations include contract complexity, product allocation concerns during periods of high demand, and pricing that may not be the lowest available for every product category. A purchasing team should compare the full contract, including minimum order quantities, freight, rebates, substitutions, back-order procedures, and the availability of equivalent safety and nonsafety models.

Greiner Bio-One

Greiner Bio-One is a major international supplier of blood collection and preanalytical laboratory products. In the United States, the company is particularly well known for its VACUETTE blood collection system, which includes evacuated tubes, needles, holders, and related accessories. Facilities that use or are considering the VACUETTE platform may find it efficient to source compatible multisample needles from the same product family.

Greiner Bio-One’s strengths include its focus on preanalytical processes, a broad range of tube and needle configurations, and product options designed for routine and specialized specimen collection. A standardized platform can simplify staff training and reduce the risk of combining mismatched components.

Hospitals comparing Greiner Bio-One with other suppliers should evaluate local inventory support, distributor availability, product transition assistance, and the organization’s experience with the company’s safety-engineered designs. The correct decision depends on clinical performance and total operating cost, not just whether the facility already uses Greiner tubes.

Cardinal Health

Cardinal Health is one of the largest healthcare distributors in the United States and supplies products from many manufacturers, including blood collection needles and related phlebotomy items. Its value to healthcare facilities is often connected to distribution scale, purchasing consolidation, inventory management, and the ability to combine phlebotomy products with a broader medical-surgical order.

For hospitals and multisite systems, a distributor such as Cardinal Health may reduce the number of purchase orders, invoices, deliveries, and vendor-management tasks. Facilities may also be able to negotiate pricing through a health-system agreement or group purchasing arrangement. The distributor can be especially useful when the facility wants access to multiple brands rather than committing to one manufacturer.

Buyers should confirm the actual manufacturer and product identification number for each needle. A distributor’s catalog may include several products that appear similar but differ in gauge, length, safety mechanism, packaging, sterility, or tube-holder compatibility. Contracted pricing should also be reviewed against current market conditions because distributor fees, freight charges, and substitution rules can affect the effective cost.

McKesson

McKesson is another major U.S. healthcare distributor with extensive reach across hospitals, physician practices, ambulatory centers, laboratories, and other care settings. It offers access to numerous blood collection and phlebotomy products, including multisample needles from established manufacturers and private-label lines.

McKesson may be a practical choice for facilities that prioritize broad catalog access, regular delivery schedules, and consolidated purchasing. Smaller practices can benefit from the convenience of ordering needles alongside syringes, gloves, disinfectants, specimen containers, and other consumables. Larger organizations should examine regional distribution capabilities and service-level commitments for every delivery location.

When comparing McKesson with other distribution partners, purchasers should calculate landed cost. This calculation should include the product price, shipping, fuel or handling fees, emergency-order charges, storage requirements, and the labor required to manage back orders. A slightly higher unit price may be justified if it produces better fill rates and fewer urgent purchases.

Medline

Medline is a major manufacturer and distributor of medical supplies and offers a wide range of products used in phlebotomy and specimen collection. Its catalog includes needles, safety devices, holders, blood collection sets, tubes, sharps containers, personal protective equipment, and other supplies used during Venipuncture.

Medline can be attractive to healthcare facilities seeking a broad medical-surgical relationship. Standardizing several categories with one supplier may create administrative efficiencies and support systemwide product conversions. Medline’s distribution capabilities are also relevant for outpatient clinics and healthcare networks that need consistent availability across multiple sites.

Facilities should nevertheless verify whether a product is manufactured by Medline or sourced from another manufacturer. They should review regulatory documentation, lot traceability, packaging, and replacement procedures for each specific item. A private-label product may perform well, but it should be evaluated with the same rigor applied to a nationally recognized brand.

Henry Schein

Henry Schein is a significant distributor serving physician offices, ambulatory care facilities, dental practices, specialty clinics, and other healthcare organizations. It can be a useful supplier for smaller medical practices that do not have the purchasing volume of a hospital system but still require dependable access to needles and blood collection accessories.

The company’s value is often based on convenience, catalog breadth, customer service, and the ability to combine laboratory and clinical supplies in one order. Smaller facilities may also appreciate ordering tools that make recurring purchases easier to manage.

Before selecting a supplier, an office should determine whether the available needle products meet its safety and performance requirements. A low-volume practice may pay more per box than a large hospital, but it can still control costs by establishing standard gauges, monitoring usage, avoiding unnecessary product variation, and maintaining a small but appropriate safety stock.

How to Compare Suppliers Objectively

A formal product evaluation helps prevent purchasing decisions based on brand familiarity or temporary promotional pricing. A healthcare organization should create a weighted scorecard that reflects its clinical and operational priorities.

1. Regulatory status: Confirm that the product is legally marketed in the United States and that the supplier can provide appropriate device documentation, labeling, lot information, and quality records.
2. Safety performance: Evaluate whether the device has a safety feature, whether it can be activated with one hand when appropriate, and whether activation is easy to confirm visually or by touch.
3. Compatibility: Confirm fit with the existing tube holder, evacuated tube system, sharps container, and collection procedure.
4. Clinical usability: Ask phlebotomists and nurses to assess needle sharpness, bevel quality, stability, tube changes, leakage, activation, and disposal.
5. Supply reliability: Review historical fill rates, lead times, back-order communication, allocation policies, and emergency-order support.
6. Total cost: Include unit price, freight, storage, waste, staff time, failed draws, redraws, needlestick investigations, and product-conversion costs.
7. Training and implementation: Determine whether the supplier provides education, samples, competency materials, and on-site or virtual implementation support.
8. Reporting and traceability: Ensure that lot numbers, expiration dates, recalls, complaints, and adverse events can be tracked efficiently.

A scorecard can assign different weights to each category. For example, a hospital with a large phlebotomy department may assign greater weight to safety and supply continuity, while a small physician office may emphasize ease of ordering and low minimum quantities. The scoring method should be documented so that the final decision can be explained to clinical leadership, finance, and compliance personnel.

Safety and Regulatory Considerations

Needlestick prevention is a central issue in blood collection procurement. OSHA’s Bloodborne Pathogens Standard requires covered employers to use engineering and work-practice controls to eliminate or minimize employee exposure to blood and other potentially infectious materials. The standard also requires an exposure-control plan, employee training, personal protective measures, regulated-waste procedures, and documentation.

OSHA’s 2001 revisions to the standard emphasized safer medical devices, soliciting input from nonmanagerial employees who are responsible for direct patient care, and documenting consideration and implementation of safer alternatives. For a healthcare facility, this means that a needle-conversion project should involve the people who actually perform Venipuncture. A product that appears attractive in a catalog may be difficult to activate, unstable during tube changes, or unsuitable for particular patient populations.

The Centers for Disease Control and Prevention and the National Institute for Occupational Safety and Health have also highlighted the continuing risk of occupational exposure to blood. Older national estimates commonly cited by NIOSH place hospital-based needlestick and sharps injuries at approximately 385,000 annually, or roughly 1,000 injuries per day in hospital settings. The actual number is likely higher when outpatient settings, unreported incidents, and nonhospital workers are considered. These figures demonstrate why safety design and staff behavior remain important purchasing criteria.

Facilities should distinguish between a safety needle and a needle that merely has a protective component. The device should reduce risk throughout the procedure and after use. Buyers should assess whether the safety mechanism can be activated immediately after the draw, whether it remains secure during transport to the sharps container, and whether it creates any new risk such as accidental activation or poor visibility of the Venipuncture site.

The U.S. Food and Drug Administration regulates needles and blood collection devices as medical devices. Procurement teams should maintain product records, review labeling, and confirm that intended use, sterility, packaging, and storage requirements are appropriate. The FDA’s Unique Device Identification system also supports product identification and traceability. Organizations should capture the device identifier and lot information in their inventory and recall-management processes when applicable.

Product Specifications That Matter

Gauge and Length

Gauge selection affects blood flow, patient comfort, and the suitability of the device for a particular vein. A smaller gauge number represents a larger internal diameter. Twenty-one-gauge needles are common for routine adult blood draws, while 22-gauge and 23-gauge needles may be selected for smaller veins or patients with more delicate access. However, a needle that is too small for the required collection can increase collection time or contribute to hemolysis under unfavorable conditions.

Length should match the patient and collection technique. Most routine Venipuncture does not require an unusually long needle, but specialized clinical situations may. Facilities should avoid excessive product variety while retaining enough options for pediatric, geriatric, bariatric, oncology, and difficult-access patients.

Needle Sharpness and Bevel Quality

A well-manufactured bevel can reduce insertion force and patient discomfort. During product trials, staff should record first-stick success, patient-reported discomfort, visible trauma, and the frequency of redraws. These measurements are more useful than general impressions alone.

Tube Holder Design

Needles and holders should be evaluated as a system. The holder must be stable, easy to grip, and compatible with the facility’s evacuated tubes. Threaded connections should remain secure during tube changes. The organization should also determine whether holders are single-use or reusable under its infection-prevention policy. Many facilities use single-use holders to reduce Cross-Contamination risk.

Packaging and Sterility

Packaging should protect the needle from damage and make the gauge, length, expiration date, lot number, and safety status easy to identify. Sterile packaging should remain intact during shipping and storage. Facilities should establish procedures for segregating damaged, expired, or recalled products.

Cost, Contracting, and Inventory Management

Needles are relatively inexpensive compared with many medical devices, but the total financial impact can be substantial because phlebotomy departments may use tens of thousands or millions of units annually. A health system should calculate annual consumption by department, site, gauge, and product type before negotiating.

Unit price is only one part of the economic analysis. A needle that costs a few cents more may be financially preferable if it reduces failed draws, repeat collections, staff injuries, or product waste. Conversely, a premium safety product may not provide value if staff cannot activate it reliably or if the facility does not maintain an effective disposal process.

Contract discussions should address price protection, rebate thresholds, freight, order minimums, substitutions, back orders, emergency deliveries, and product discontinuation notices. If a supplier offers a volume discount, the buyer should verify that the facility can realistically reach the required volume without creating excess inventory or expiration risk.

Inventory teams should establish par levels based on actual usage and lead time. A common approach is to hold routine stock plus a safety reserve for unexpected demand or supply interruptions. The reserve should be large enough to protect patient care but not so large that products expire. Barcode scanning, automated replenishment, and regular cycle counts can improve visibility.

The Covid-19 pandemic demonstrated how quickly demand and supply conditions can change for medical consumables. Although supply conditions vary by product and period, the experience reinforced the importance of dual sourcing, accurate consumption data, and communication with suppliers. A facility that relies on one needle, one distributor, or one regional warehouse may face greater disruption than an organization with qualified alternatives.

Best Supplier by Facility Type

Large Hospitals and Integrated Health Systems

Large systems often benefit from direct manufacturer negotiations or contracts through a group purchasing organization. BD and Greiner Bio-One may be strong candidates when the organization wants an integrated blood collection platform. Cardinal Health, McKesson, or Medline may be appropriate when distribution consolidation, multisite delivery, and broad product access are priorities.

The best arrangement may be a primary manufacturer supported by a secondary distributor or approved alternative. The system should standardize products where practical while allowing clinically necessary exceptions.

Community Hospitals

Community hospitals should focus on dependable delivery, staff familiarity, and reasonable contract flexibility. A national distributor can simplify ordering, but direct manufacturer support may be valuable during a product conversion or safety evaluation. A community hospital should not assume that the purchasing terms offered to a large metropolitan system will be available to it; local service quality and regional stock may be equally important.

Physician Offices and Urgent Care Centers

Smaller facilities usually need modest quantities of common gauges and lengths, straightforward ordering, and low administrative burden. Henry Schein, McKesson, Cardinal Health, and Medline can all be evaluated as purchasing channels. A clinic may also buy directly from a manufacturer through an authorized distributor, provided that it can manage inventory, recalls, and documentation.

Outpatient Laboratories and Mobile Phlebotomy Services

These organizations may place a high value on portability, consistent packaging, difficult-draw options, and rapid replenishment. They should compare standard multisample needles with blood collection sets and consider how products perform in vehicles, temporary sites, and nontraditional care environments. Packaging that is easy to organize and identify can reduce errors during mobile operations.

Recommended Evaluation Process

A practical supplier-selection process can be completed in several stages. First, the facility should analyze its current products, usage, costs, adverse events, failed draws, and staff feedback. Second, it should identify required specifications and invite proposals from several manufacturers or distributors. Third, clinical staff should conduct a controlled trial using representative patients and standard procedures.

1. Define the required gauges, lengths, safety features, holder types, packaging quantities, and annual volumes.
2. Request samples and complete regulatory, quality, and supplier-risk reviews.
3. Conduct supervised trials in inpatient, outpatient, pediatric, geriatric, and difficult-access settings when relevant.
4. Measure first-stick success, redraw rates, hemolysis, staff satisfaction, activation success, and disposal performance.
5. Compare quoted pricing with freight, rebates, contract conditions, training, and projected waste.
6. Obtain approval from laboratory leadership, nursing, infection prevention, occupational health, Supply Chain, and finance.
7. Implement the selected product with education, updated procedures, inventory controls, and a defined escalation process.
8. Review performance at regular intervals and after any safety event, recall, major back order, or product change.

Staff education should occur before the conversion date. Even a familiar-looking safety needle may operate differently from the previous model. Training should cover insertion, tube changes, activation, disposal, exposure response, and reporting. Competency checks are particularly important for employees who perform infrequent blood draws.

Final Guidance for U.S. Healthcare Buyers

There is no single best supplier for every U.S. healthcare facility. BD and Greiner Bio-One are leading manufacturer options for organizations seeking established blood collection systems. Cardinal Health, McKesson, and Medline offer extensive distribution and medical-surgical purchasing capabilities. Henry Schein is often practical for physician offices and smaller ambulatory organizations. Other qualified manufacturers and regional distributors may be competitive when they provide the required documentation, product consistency, safety design, and service.

The strongest purchasing decision combines clinical validation with supply-chain discipline. Facilities should confirm that the needle is compatible with the tube and holder system, evaluate safety performance under real working conditions, and calculate total cost rather than focusing only on the box price. They should also maintain accurate lot traceability, use appropriate sharps-disposal practices, and involve frontline employees in product selection.

In an environment where patient volumes, staffing levels, Regulations, and supply conditions continue to change, supplier reliability is a clinical issue as well as a financial issue. A vendor that consistently delivers the correct product, supports training, communicates about shortages, and responds promptly to quality concerns can provide more value than a vendor offering a lower initial price. For most healthcare organizations, the best strategy is to qualify several suppliers, select a primary product based on evidence, maintain an approved alternative, and reassess performance using measurable data.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Related Videos